Key result
Among hospitalized patients undergoing left atrial appendage occlusion, women had a higher risk of major in-hospital adverse events compared to men.
Why the study?
Are there gender disparities in the utilization and clinical outcomes of left atrial appendage occlusion?
Are there gender disparities in the utilization and clinical outcomes of left atrial appendage occlusion?
Answers are grounded in this paper and cite their sources.
Highlights significant gender disparities in the utilization and clinical outcomes of left atrial appendage occlusion, emphasizing the need for interventions to address them.
Patients with atrial fibrillation are at increased risk of thromboembolic events, in which most of these patients meet criteria to be under chronic oral anticoagulation treatment. Left atrial appendage occlusion (LAAO) emerged as an alternative to reduce the risk of embolic events without the need of long-term oral anticoagulation. Gender disparities in selection, usage, and clinical outcomes has been described in many interventional cardiology scenarios. It is unknown if LAAO procedures are underutilized or clinical outcomes differ by gender. Osman and collaborators performed an analysis on patients who underwent LAAO procedures from October 2015 to December 2017 in the National Readmission Database. The primary endpoint was major in-hospital adverse events, while secondary endpoints were 30-day readmission rate, nonhome discharge and hospitalization cost. Propensity score matching was done to compare the outcomes between genders. A total of 9,281 patients were included, 3,659 were women (39%) and 5,622 were men (61%). Comparing to men, women had lower prevalence of diabetes (30.6% vs. 35.7%, p < .01), heart failure (28.6% vs. 30.8%, p = .03), vascular disease (55.5% vs. 69.6%, p < .01), and renal failure (18.3% vs. 21.2%, p < .01) and higher CHA2DS2VASc score (5 [IQR4-6] vs. 4 [IQR3-6], p < .01). After propensity-score matching, women experienced a higher risk of major in-hospital adverse events (2.8% vs. 1.9%; p < .01), and nonhome discharges (11.4% vs. 6.7%; p < .01). Furthermore, 30-day readmission rate was higher in women (10% vs. 8.6%, p = .03). Authors conclude that among hospitalized patients undergoing LAAO, women are at higher risk for major in-hospital adverse events, nonhome discharge and 30-day readmission rates. Although stroke prevention strategies should be equal between genders, this report finds evidence of a treatment gap not favoring women. A compelling reason to expect the opposite is that women experience larger or worst strokes compared to men. This study not only report that women represented just 39% of this national database, but also indirect evidence of a higher threshold for advancing women to an LAAO procedure, including more frequent prior history of ischemic cerebrovascular events and higher CHA2DS2VASc score. The evidence suggesting a more delayed indication for LAAO among women may, at least partially, explain the observed increase in procedural complications. During the last decade, we seem to be facing a pandemic of gender disparities, in which women are consistently associated with lower resource utilization and worse clinical results when compared to men. More efforts are needed to better understand the root of the problem and implement interventions to reverse this situation. Our society and healthcare system should guarantee equity in the management of cardiovascular diseases between women and men.
No takes yet. Share an insight, caveat, or question.
Belardi et al. (2021) conducted an editorial in Atrial fibrillation undergoing LAAO (n=9,281). Female gender vs. Male gender was evaluated on Major in-hospital adverse events (p=< .01). Among hospitalized patients undergoing left atrial appendage occlusion, women had a higher risk of major in-hospital adverse events compared to men.
Synapse has enriched 10 related papers. Consider them for comparative context: